RHEB and Parkinson disease: Therefore, viral transduction of hippocampal neurons through methods such as AAV1-Rheb(S16H) administration, resulting in the sustained expression of beneficial target genes, is a potential therapeutic approach for neurodegenerative diseases such as AD and PD [16,17,18,31,32].